Position in SGMT
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$844,502
+$62,001 QoQ
Shares Held
109,250
-27.1% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#1
of 1 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SGMT Over Time
Shares Held
Position Value (USD)
Derivatives in SGMT
reported options exposure · as of Dec 31, 2025CallValue
$1,716
CallShares
290
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026FNY Investment Advisers, LLC holds $19,945,542 across 57 Biotechnology names. SGMT ranks #3 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NUVL |
Nuvalent, Inc.
|
108,951 | $13,455,448 | |
| 2 | ABVX |
Abivax S.A.
|
7,605 | $1,013,442 | |
| 3 | SGMT |
Sagimet Biosciences Inc.
This page
|
109,250 | $844,502 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
5,000 | $663,650 | |
| 5 | JANX |
Janux Therapeutics, Inc.
|
30,850 | $473,856 | |
| 6 | NKTR |
Nektar Therapeutics
|
5,500 | $383,955 | |
| 7 | VERU |
Veru Inc.
|
105,081 | $328,903 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
8,170 | $318,711 |
All Filings in SGMT
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $844,502 | 109,250 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $782,501 | 149,761 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $845,855 | 142,881 | Shares | Sole | 2026-01-16 | |
| 2025-12-31 | $1,716 | 290 | Call | Sole | 2026-01-16 | |
| 2025-09-30 | $1,029 | 150 | Call | Sole | 2025-12-15 | |
| 2025-09-30 | $759,059 | 110,650 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $660,989 | 86,744 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,532 | 470 | Call | Sole | 2025-04-17 | |
| 2025-03-31 | $590,060 | 181,000 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $586,125 | 130,250 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $105 | 38 | Call | Sole | 2024-10-18 | |
| 2024-09-30 | $409,735 | 147,919 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $543,581 | 158,942 | Shares | Sole | 2024-08-05 | |
| 2024-06-30 | $513 | 150 | Call | Sole | 2024-08-05 | |
| 2024-03-31 | $181,570 | 33,500 | Shares | Sole | 2024-05-03 | |
| No filing history on record for this holder in this stock. | ||||||